Delivery Order SPE2DB22D9319-SPE2DB24FK2NC

Award Date 7/17/24
Potential Completion Date 8/7/24
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract, valued at $5,717.52, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, and it has an ultimate completion date of September 9, 2024. DMS...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,144.07, was awarded on February 9, 2024, to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, and it has an ultimate completion date of March 4,...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $8,204.88 and a completion date of January 19, 2024. This award is part of a larger $499,999,999 indefinite delivery contract...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $3,573.45 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
The federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $8,576.28 and an ultimate completion date of October 17, 2024. DMS Pharmaceutical Group Inc. holds a significant...
This federal contract award is for the supply of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract with a ceiling value of $35,734.50 and a performance period ending on September 17, 2024. The contract is not set-aside and...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $7,146.90 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award, valued at $28,587.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is a delivery order awarded under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to...
The federal contract award is for the purchase of NEXPLANON 68 MG IMPLANTS by the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price Delivery Order contract is valued at $7,146.90 and has a completion date of May 16, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This federal contract award is for the delivery of Nexplanon 68 mg implants to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $3,573.45, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
  • SPE2DB22D9319
    Indefinite Delivery Contract
  • SPE2DB22D9319-SPE2DB24FK2NC
    Delivery Order

This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $8,576.28 firm fixed-price contract was awarded on July 17, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of August 7, 2024 and is not designated as a set-aside.

DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the medical supply needs of Department of Defense healthcare facilities worldwide. Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group provides both routine and specialized medications, including contraceptives like the NEXPLANON implant, to military personnel and their dependents across various DoD medical facilities.

Generated 10/16/24, 9:21 AM